U.S., Jan. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07319897) titled 'A Prospective, Multicenter, Diagnostic Study Evaluating 68Ga-BCMA PET/CT for Targeting BCMA Expression in Multiple Myeloma.' on Dec. 20, 2025.
Brief Summary: This is a prospective, multicenter, diagnostic imaging study designed to evaluate the diagnostic performance and clinical utility of BCMA-targeted Positron Emission Tomography/Computed Tomography (PET/CT) in patients with multiple myeloma and other palsma cell disorders. The study aims to non-invasively visualize and quantify the whole-body biodistribution of BCMA expression.
Study Start Date: Dec. 25, 2025
Study Type: INTERVENTIONAL
Condition:
Multiple Myeloma
Multiple Myel...